Drug-free Migraine Treatment
Total Trials
22
As Lead Sponsor
21
As Collaborator
1
Total Enrollment
104,069
NCT02453399
Relief of Migraine Pain Through Electro Stimulation
Phase: N/A
Role: Lead Sponsor
Start: Jul 31, 2015
Completion: May 31, 2016
NCT03076515
Migraine Treatment With Nerivio Migra Neurostimulation Device
Start: Apr 2, 2017
Completion: Apr 1, 2018
NCT03361423
Evaluation of a Novel Device for Treatment of Migraine Headache
Start: Dec 17, 2017
Completion: Dec 25, 2018
NCT04161807
Efficacy and Safety of Nerivio™ for Acute Treatment of Migraine in People With Chronic Migraine
Start: Sep 18, 2019
Completion: Feb 18, 2020
NCT04089761
Safety and Efficacy of Nerivio™ for the Acute Treatment of Migraine in Adolescents
Start: Oct 1, 2019
Completion: May 24, 2020
NCT04194008
Efficacy and Safety of Nerivio Device for Acute Treatment of Migraine in People With Chronic Migraine
Start: Nov 18, 2019
Completion: Aug 30, 2020
NCT04600388
Efficacy and Safety of Nerivio for the Acute Treatment of Menstrual Migraine
Start: Sep 9, 2020
Completion: Nov 10, 2020
NCT04828707
Assessment of Safety and Efficacy of Nerivio for the Migraine Prevention
Start: Apr 13, 2021
Completion: Oct 10, 2022
NCT04992897
Real-world Data Analysis of REN Treatment in Migraine Patients
Start: Jun 15, 2021
Completion: Aug 10, 2021
NCT05310227
Nerivio Device for Treatment of New Daily Headache Persistence (NDHP)
Role: Collaborator
Start: Feb 1, 2022
Completion: Sep 11, 2023
NCT05443659
Real-world Data Analysis of REN Treatment in Adolescence with Migraine
Start: Jul 28, 2022
Completion: Aug 24, 2022
NCT05464069
Safety of Nerivio in Pregnant Women With Migraine
Start: Aug 1, 2022
Completion: Dec 7, 2022
NCT05760638
Real-World Evidence (RWE) Data Analysis of 1-year Consecutive Use of Remote Electrical Neuromodulation (REN)
Start: Mar 1, 2023
Completion: Apr 2, 2023
NCT05769322
Real World Data Analysis: Impact of High-Frequency REN Treatments As Migraine Preventive Therapy in Adolescence
Start: Apr 1, 2023
Completion: May 1, 2023
NCT06023953
Migraine With and Without Aura Characteristics and Response to Remote Electrical Neuromodulation (REN) Treatment
Start: Jul 1, 2023
Completion: Dec 1, 2024
NCT05940870
A Prospective Post-marketing Observational Study Assessing the Safety and Efficacy of Nerivio for Migraine Prevention.
Start: Jul 3, 2023
Completion: Aug 1, 2024
NCT06138756
Acute Treatment of Migraine in Pre-Adolescents: Real-World Analysis of Remote Electrical Neuromodulation (REN)
Start: Oct 1, 2023
Completion: Jun 1, 2024
NCT06180577
A Survey Study to Assess the Accessibility of the Nerivio Device At School
Start: Feb 1, 2024
Completion: May 15, 2024
NCT06271746
Treatment of Fibromyalgia With the FibroNova Neuromodulation Device
Start: Mar 4, 2024
Completion: Jun 1, 2025
NCT06738056
Nerivio Long-term Usage in Patients With Migraine
Start: Dec 1, 2024
Completion: Dec 22, 2024
NCT06976723
Nerivio Efficacy by Time of Treatment Onset
Phase: Phase 4
Start: May 7, 2025
Completion: Jun 15, 2025
NCT05523310
Observational Study to Assess Migraine Prediction Tool
Start: Jan 1, 2030
Completion: Nov 15, 2030
Loading map...